Merck Keytruda formulations undergo FDA priority review for bladder cancer

Merck (MRK) stock is in focus as the company's Keytruda versions win FDA priority review for an expanded indication in ...

ESMO 2025: Padcev plus Keytruda promising in first-line advanced HNSCC

"ESMO 2025: Padcev plus Keytruda promising in first-line advanced HNSCC" was originally created and published by Clinical ...
CURE

Cancer Vaccine Plus Keytruda Slow Advanced Melanoma Progression

IO102-IO103 plus Keytruda improved median PFS by 8.4 months over Keytruda alone in advanced melanoma patients. The ...

2 Beaten-Down Stocks to Buy and Hold for the Next Decade

The pharmaceutical company has also earned approval for Wegovy in treating metabolic dysfunction-associated steatohepatitis ...

KEYTRUDA® (pembrolizumab) Plus Padcev® (enfortumab vedotin-ejfv) Reduced Risk of Event-Free Survival Events by 60% and Risk of Death by 50% for Certain Patients …

Merck (NYSE: MRK), known as MSD outside of the United States and Canada, today announced landmark results demonstrating ...

Telomir Pharmaceuticals Reports Discovery That Telomir-1 Selectively Kills Aggressive Triple-Negative Breast Cancer Cells

New findings show Telomir-1 shuts down cellular energy pathways and mitochondrial function in aggressive breast cancer cells, leading to cell death through iron-dependent regulation. MIAMI, FL / ...
National Catholic Reporter

Pope Leo calls for 'true ecological conversion' from words to action on environment

Catholics and all people committed to protecting the planet must keep climate action from slipping into trends or tribalism, Pope Leo XIV said as he opened a global church summit on climate change ...
Phys.org

Chinese medicine extract tetrandrine's precise mechanism of action opens new avenues for drug discovery

A research team led by Prof. Ben Ko Chi-bun, Associate Professor of the PolyU Department of Applied Biology and Chemical Technology, has discovered the critical mechanism of action of tetrandrine, a ...